Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized yohimbine study in type 2 diabetes patients with ADRA2A rs553668 risk variant
2010-018604-85Phase 2Active
- Sponsor
- Lund University
- Start
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of yohimbine in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Lund University. Primary endpoint: Insulin level at 30 minutes during OGTT. Started Jun 2011; status: active.
02
Drugs
yohimbine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2010-018604-85.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018604-85.